EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of CaV1.2 Inhibitor Nifedipine on Chondrogenic Differentiation of Human Bone Marrow or Menstrual Blood-Derived Mesenchymal Stem Cells and Chondrocytes

Ilona Uzieliene iD, Daiva Bironaite, Rokas Miksiunas, Edvardas Bagdonas iD, Raminta Vaiciuleviciute, Ali Mobasheri iD, Eiva Bernotiene

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ilona Uzieliene und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, 08406 Vilnius, Lithuania. Hauptthemen laut MEDLINE: Chondrocytes, Mesenchymal Stem Cells, Nifedipine, Osteoarthritis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Structural and Social Funds through the Research Council of Lithuania, European Structural and Social Funds (ES Struktūrinės Paramos) through the Research Council of Lithuania (Lietuvos Mokslo Taryba) according to the activity Att….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cartilage is an avascular tissue and sensitive to mechanical trauma and/or age-related degenerative processes leading to the development of osteoarthritis (OA). Therefore, it is important to investigate the mesenchymal cell-based chondrogenic regenerating mechanisms and possible their regulation. The aim of this study was to investigate the role of intracellular calcium (iCa2+) and its regulation through voltage-operated calcium channels (VOCC) on chondrogenic differentiation of mesenchymal stem/stromal cells derived from human bone marrow (BMMSCs) and menstrual blood (MenSCs) in comparison to OA chondrocytes. The level of iCa2+ was highest in chondrocytes, whereas iCa2+ store capacity was biggest in MenSCs and they proliferated better as compared to other cells. The level of CaV1.2 channels was also highest in OA chondrocytes than in other cells. CaV1.2 antagonist nifedipine slightly suppressed iCa2+, Cav1.2 and the proliferation of all cells and affected iCa2+ stores, particularly in BMMSCs. The expression of the CaV1.2 gene during 21 days of chondrogenic differentiation was highest in MenSCs, showing the weakest chondrogenic differentiation, which was stimulated by the nifedipine. The best chondrogenic differentiation potential showed BMMSCs (SOX9 and COL2A1 expression); however, purposeful iCa2+ and VOCC regulation by blockers can stimulate a chondrogenic response at least in MenSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesMesenchymal Stem CellsNifedipineOsteoarthritisCalcium Channel BlockersHumansBone Marrow CellsCell DifferentiationCells, CulturedChondrogenesisCalcium Channels, L-Type

Stichwörter der Autor:innen

chondrocyteschondrogenic differentiationintracellular calcium ionsmesenchymal stem/stromal cells (MSC)voltage-operated calcium channels (VOCC)

Substanzen

NifedipineCACNA1C protein, humanCalcium Channels, L-TypeCalcium Channel Blockers

Autor:innen und Institutionen

  • Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, 08406 Vilnius, Lithuania.
  • Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, 90014 Oulu, Finland.
  • World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Aging, Université de Liège, B-4000 Liège, Belgium.
  • Department of Joint Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.

ORCID-Profile: Ilona Uzieliene, Edvardas Bagdonas, Ali Mobasheri

Förderung

  • European Structural and Social Funds through the Research Council of Lithuania
  • European Structural and Social Funds (ES Struktūrinės Paramos) through the Research Council of Lithuania (Lietuvos Mokslo Taryba) according to the activity Att…

Zitieren

APA

Uzieliene, I., Bironaite, D., Miksiunas, R., Bagdonas, E., Vaiciuleviciute, R., Mobasheri, A., & Bernotiene, E. (2023). The Effect of CaV1.2 Inhibitor Nifedipine on Chondrogenic Differentiation of Human Bone Marrow or Menstrual Blood-Derived Mesenchymal Stem Cells and Chondrocytes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076730

Vancouver

Uzieliene I, Bironaite D, Miksiunas R, Bagdonas E, Vaiciuleviciute R, Mobasheri A, et al. The Effect of CaV1.2 Inhibitor Nifedipine on Chondrogenic Differentiation of Human Bone Marrow or Menstrual Blood-Derived Mesenchymal Stem Cells and Chondrocytes. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076730

BibTeX
@article{Uzieliene2023,
  author = {Uzieliene, Ilona and Bironaite, Daiva and Miksiunas, Rokas and Bagdonas, Edvardas and Vaiciuleviciute, Raminta and Mobasheri, Ali and Bernotiene, Eiva},
  title = {The Effect of CaV1.2 Inhibitor Nifedipine on Chondrogenic Differentiation of Human Bone Marrow or Menstrual Blood-Derived Mesenchymal Stem Cells and Chondrocytes},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076730}
}
Kostenlos starten →